Cigna Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.06M | Sell |
7,550
-91
| -1% | -$93K | 1.17% | 13 |
|
|
2026
Q1 | $7.03M | Sell |
7,641
-95
| -1% | -$96.3K | 1.08% | 14 |
|
|
2025
Q4 | $8.31M | Sell |
7,736
-84
| -1% | -$80.3K | 1.2% | 14 |
|
|
2025
Q3 | $5.97M | Sell |
7,820
-67
| -0.8% | -$49.9K | 0.84% | 14 |
|
|
2025
Q2 | $6.15M | Sell |
7,887
-172
| -2% | -$134K | 1.05% | 13 |
|
|
2025
Q1 | $6.66M | Sell |
8,059
-176
| -2% | -$146K | 1.24% | 13 |
|
|
2024
Q4 | $6.36M | Sell |
8,235
-44
| -0.5% | -$36.4K | 1.11% | 13 |
|
|
2024
Q3 | $7.33M | Sell |
8,279
-532
| -6% | -$478K | 1.29% | 12 |
|
|
2024
Q2 | $7.98M | Sell |
8,811
-87
| -1% | -$69.6K | 1.48% | 9 |
|
|
2024
Q1 | $6.92M | Sell |
8,898
-65
| -0.7% | -$46.3K | 1.3% | 10 |
|
|
2023
Q4 | $5.22M | Sell |
8,963
-34
| -0.4% | -$19.8K | 1.07% | 12 |
|
|
2023
Q3 | $4.83M | Sell |
8,997
-1,092
| -11% | -$563K | 1.1% | 13 |
|
|
2023
Q2 | $4.73M | Sell |
10,089
-22
| -0.2% | -$9.23K | 0.88% | 17 |
|
|
2023
Q1 | $3.47M | Sell |
10,111
-186
| -2% | -$62.7K | 0.69% | 23 |
|
|
2022
Q4 | $3.77M | Buy |
10,297
+20
| +0.2% | +$7.09K | 0.78% | 20 |
|
|
2022
Q3 | $3.32M | Sell |
10,277
-443
| -4% | -$140K | 0.73% | 22 |
|
|
2022
Q2 | $3.48M | Sell |
10,720
-3,813
| -26% | -$1.14M | 0.69% | 27 |
|
|
2022
Q1 | $4.16M | Sell |
14,533
-3,823
| -21% | -$984K | 0.51% | 33 |
|
|
2021
Q4 | $5.07M | Sell |
18,356
-6,412
| -26% | -$1.63M | 0.4% | 43 |
|
|
2021
Q3 | $5.72M | Sell |
24,768
-443
| -2% | -$109K | 0.43% | 47 |
|
|
2021
Q2 | $5.79M | Sell |
25,211
-3,861
| -13% | -$776K | 0.41% | 48 |
|
|
2021
Q1 | $5.43M | Buy |
29,072
+681
| +2% | +$133K | 0.37% | 53 |
|
|
2020
Q4 | $4.79M | Buy |
28,391
+1,664
| +6% | +$248K | 0.37% | 56 |
|
|
2020
Q3 | $3.96M | Sell |
26,727
-7,866
| -23% | -$1.22M | 0.38% | 56 |
|
|
2020
Q2 | $5.68M | Buy |
34,593
+3,128
| +10% | +$480K | 0.54% | 37 |
|
|
2020
Q1 | $4.37M | Buy |
31,465
+1,491
| +5% | +$205K | 0.56% | 34 |
|
|
2019
Q4 | $4.18M | Buy |
29,974
+4,767
| +19% | +$553K | 0.44% | 41 |
|
|
2019
Q3 | $2.87M | Buy |
25,207
+850
| +3% | +$94.6K | 0.3% | 70 |
|
|
2019
Q2 | $2.65M | Sell |
24,357
-901
| -4% | -$106K | 0.29% | 69 |
|
|
2019
Q1 | $3.28M | Sell |
25,258
-4,700
| -16% | -$572K | 0.36% | 59 |
|
|
2018
Q4 | $3.47M | Buy |
29,958
+1,959
| +7% | +$219K | 0.29% | 48 |
|
|
2018
Q3 | $3.04M | Sell |
27,999
-2,565
| -8% | -$256K | 0.24% | 58 |
|
|
2018
Q2 | $2.61M | Sell |
30,564
-5,019
| -14% | -$412K | 0.19% | 76 |
|
|
2018
Q1 | $2.75M | Sell |
35,583
-271
| -0.8% | -$21.8K | 0.18% | 77 |
|
|
2017
Q4 | $3.03M | Sell |
35,854
-1,502
| -4% | -$128K | 0.2% | 70 |
|
|
2017
Q3 | $3.19M | Sell |
37,356
-4,421
| -11% | -$363K | 0.21% | 65 |
|
|
2017
Q2 | $3.44M | Buy |
41,777
+159
| +0.4% | +$13K | 0.24% | 56 |
|
|
2017
Q1 | $3.5M | Buy |
41,618
+5,774
| +16% | +$462K | 0.24% | 60 |
|
|
2016
Q4 | $2.64M | Buy |
+35,844
| New | +$2.67M | 0.29% | 66 |
|
Other funds holding LLY
Cigna Investments's LLY Position: Q2 2026 in Review
Cigna Investments reduced its Eli Lilly (LLY) stake by 1.2% in Q2 2026, selling an estimated $93K and leaving 7,550 shares worth $9.06M. The position accounts for 1.17% of the portfolio, ranked #13.
Cigna Investments first reported a position in LLY in Q4 2016 and has held it in 39 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Cigna Investments held 7,550 shares of Eli Lilly worth $9.06M as of Q2 2026.
- Cigna Investments sold 91 Eli Lilly shares in Q2 2026, an estimated $93K.
- Eli Lilly made up 1.17% of Cigna Investments's portfolio in Q2 2026, its #13 holding.
- Cigna Investments first reported a position in Eli Lilly in Q4 2016 and has held it in 39 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.